Estrogen receptor alpha and matrix metalloproteinase 2 polymorphisms and age-related maculopathy in older women

American Journal of Epidemiology

Volumn 167, Issue 10, 2008, Pages 1217-1225

  Seitzman, Robin L ^a,k   Mahajan, Vinit B ^b   Mangione, Carol ^a   Cauley, Jane A ^c   Ensrud, Kristine E ^d,e   Stone, Katie L ^f   Cummings, Steven R ^f,g   Hochberg, Marc C ^h   Hillier, Teresa A ⁱ   Sinsheimer, Janet S ^a,j   Yu, Fei ^a,j   Coleman, Anne L ^a,j  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

ⁱ CENTER FOR HEALTH RESEARCH   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k BIOGEN   (United States)

more..

Author keywords

Estrogen receptor alpha; Macular degeneration; Matrix metalloproteinase 2; Polymorphism, single nucleotide

Indexed keywords

ESTROGEN RECEPTOR ALPHA; GELATINASE A; MMP2 PROTEIN, HUMAN;

AGING; AGING POPULATION; ALLELE; BONE; ENZYME ACTIVITY; ESTROGENIC COMPOUND; EYE DISEASE; HORMONE; OSTEOLOGY; PHOTOGRAPH; POLYMORPHISM; WOMENS HEALTH;

AGED; ALLELE; ARTICLE; CAUCASIAN; CONFIDENCE INTERVAL; CONTROLLED STUDY; EYE FUNDUS; EYE PHOTOGRAPHY; FEMALE; FOLLOW UP; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREVALENCE; RANDOM SAMPLE; RATING SCALE; RETINA MACULA AGE RELATED DEGENERATION; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; WISCONSIN AGE RELATED MACULOPATHY GRADING SYSTEM; EPIDEMIOLOGY; ESTROGEN THERAPY; GENE FREQUENCY; GENETIC LINKAGE; GENETICS; GENOTYPE; HOSPITALIZATION; PATHOLOGY; PIGMENT EPITHELIUM; POLYMERASE CHAIN REACTION; POSTMENOPAUSE OSTEOPOROSIS; RETINA MACULA DEGENERATION;

AGED; AGED, 80 AND OVER; CONFOUNDING FACTORS (EPIDEMIOLOGY); ESTROGEN RECEPTOR ALPHA; ESTROGEN REPLACEMENT THERAPY; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LINKAGE (GENETICS); LOGISTIC MODELS; MACULAR DEGENERATION; MATRIX METALLOPROTEINASE 2; OSTEOPOROSIS, POSTMENOPAUSAL; PIGMENT EPITHELIUM OF EYE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; SEVERITY OF ILLNESS INDEX;

EID: 43249117250     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwn024     Document Type: Article

References (47)

1. Klein R, Wang Q, Klein BE, et al. The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Vis Sci 1995;36:182-91.
2. Friedman DS, O'Colmain BJ, Munoz B, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 2004;122:564-72.
3. Bureau of the Census, US Department of Commerce. Interim projections: population under age 18 and 65 and older: 2000, 2010, and 2030. Washington, DC: US Department of Commerce, 2006. (http://www.census.gov/population/www/ projections/projectionsagesex.html). (Accessed April 20, 2006).
4. Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005;308:385-9.
5. Edwards AO, Ritter R 3rd, Abel KJ, et al. Complement factor H polymorphism and age-related macular degeneration. Science 2005;308:421-4.
6. Haines JL, Hauser MA, Schmidt S, et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005;308:419-21.
7. Hageman GS, Anderson DH, Johnson LV, et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A 2005;102:7227-32.
8. Rivera A, Fisher SA, Fritsche LG, et al. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet 2005;14:3227-36.
9. Jakobsdottir J, Conley YP, Weeks DE, et al. Susceptibility genes for age-related maculopathy on chromosome 10q26. Am J Hum Genet 2005;77:389-407.
10. Yang Z, Camp NJ, Sun H, et al. A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science 2006;314:992-3.
11. Dewan A, Liu M, Hartman S, et al. HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 2006;314:989-92.
12. Gold B, Merriam JE, Zernant J, et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet 2006;38:458-62.
13. The Eye Disease Case-Control Study Group. Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol 1992;110:1701-8.
14. Klein BE, Klein R, Jensen SC, et al. Are sex hormones associated with age-related maculopathy in women? The Beaver Dam Eye Study. Trans Am Ophthalmol Soc 1994;92:289-95.
15. Vingerling JR, Dielemans I, Witteman JC, et al. Macular degeneration and early menopause: a case-control study. BMJ 1995;310:1570-1.
16. Smith W, Mitchell P, Wang JJ. Gender, oestrogen, hormone replacement and age-related macular degeneration: results from the Blue Mountains Eye Study. Aust N Z J Ophthalmol 1997;25(suppl 1):S13-15.
17. Klein BE, Klein R, Lee KE. Reproductive exposures, incident age-related cataracts, and age-related maculopathy in women: The Beaver Dam Eye Study. Am J Ophthalmol 2000;130:322-6.
18. Snow KK, Cote J, Yang W, et al. Association between reproductive and hormonal factors and age-related maculopathy in postmenopausal women. Am J Ophthalmol 2002;134:842-8.
19. Abramov Y, Borik S, Yahalom C, et al. The effect of hormone therapy on the risk for age-related maculopathy in postmenopausal women. Menopause 2004;11:62-8.
20. Defay R, Pinchinat S, Lumbroso S, et al. Sex steroids and age-related macular degeneration in older French women: The POLA Study. Ann Epidemiol 2004;14:202-8.
21. Nirmalan PK, Katz J, Robin AL, et al. Female reproductive factors and eye disease in a rural South Indian population: The Aravind Comprehensive Eye Survey. Invest Ophthalmol Vis Sci 2004;45:4273-6.
22. Seitzman RL, Mangione CM, Cauley JA, et al. Bone mineral density and age-related maculopathy in older women. J Am Geriatr Soc 2007;55:740-6.
23. Marin-Castano ME, Elliot SJ, Potier M, et al. Regulation of estrogen receptors and MMP-2 expression by estrogens in human retinal pigment epithelium. Invest Ophthalmol Vis Sci 2003;44:50-9.
24. Puistola U, Westerlund A, Kauppila A, et al. Regulation of 72-kd type IV collagenase-matrix metalloproteinase-2 by estradiol and gonadotropin-releasing hormone agonist in human granulosa-lutein cells. Fertil Steril 1995;64:81-7.
25. Zarbin MA. Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol 2004;122:598-614.
26. Cousins SW, Marin-Castano ME, Espinosa-Heidmann DG, et al. Female gender, estrogen loss, and sub-RPE deposit formation in aged mice. Invest Ophthalmol Vis Sci 2003;44:1221-9.
27. Amin S, Chong NH, Bailey TA, et al. Modulation of sub-RPE deposits in vitro: a potential model for age-related macular degeneration. Invest Ophthalmol Vis Sci 2004;45:1281-8.
28. Espinosa-Heidmann DG, Marin-Castano ME, Pereira-Simon S, et al. Gender and estrogen supplementation increases severity of experimental choroidal neovascularization. Exp Eye Res 2005;80:413-23.
29. Berglin L, Sarman S, van der Ploeg I, et al. Reduced choroidal neovascular membrane formation in matrix metalloproteinase-2-deficient mice. Invest Ophthalmol Vis Sci 2003;44:403-8.
30. Kvanta A, Shen WY, Sarman S, et al. Matrix metalloproteinase (MMP) expression in experimental choroidal neovascularization. Curr Eye Res 2000;21:684-90.
31. Plantner JJ, Jiang C, Smine A. Increase in interphotoreceptor matrix gelatinase A (MMP-2) associated with age-related macular degeneration. Exp Eye Res 1998;67:637-45.
32. Boekhoorn SS, Vingerling JR, Uitterlinden AG, et al. Estrogen receptor a gene polymorphisms associated with incident aging macula disorder. Invest Ophthalmol Vis Sci 2007;48:1012-17.
33. Price SJ, Greaves DR, Watkins H. Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation. J Biol Chem 2001;27:7549-58.
34. Klein R, Davis MD, Magli YL, et al. The Wisconsin Age-Related Maculopathy Grading System. Ophthalmology 1991;98:1128-34.
35. Klein R, Meuer SM, Moss SE, et al. Detection of drusen and early signs of age-related maculopathy using a nonmydriatic camera and a standard fundus camera. Ophthalmology 1992;99:1686-92.
36. Klein R, Klein BE, Jensen SC, et al. Age-related maculopathy in a multiracial United States population: The National Health and Nutrition Examination Survey III. Ophthalmology 1999;106:1056-65.
37. Klein R, Klein BE, Jensen SC, et al. The relationship of ocular factors to the incidence and progression of age-related maculopathy. Arch Ophthalmol 1998;116:506-13.
38. Cheng S, Grow MA, Pallaud C, et al. A multilocus genotyping assay for candidate markers of cardiovascular disease risk. Genome Res 1999;9:936-49.
39. Lange K, Cantor R, Horvath S, et al. MENDEL version 4.0: a complete package for the exact genetic analysis of discrete traits in pedigree and population data sets. Am J Hum Genet 2001;69(suppl):A1886.
40. Lange K, Sinsheimer JS, Sobel E. Association testing with Mendel. Genet Epidemiol 2005;29:36-50.
41. Rubin DB. Multiple imputation for nonresponse in surveys. New York, NY: John Wiley and Sons, Inc, 1987.
42. Schafer JL. Analysis of incomplete multivariate data. New York, NY: Chapman and Hall, Inc, 1997.
43. Sethi CS, Bailey TA, Luthert PJ, et al. Matrix metalloproteinase biology applied to vitreoretinal disorders. Br J Ophthalmol 2000;84:654-66.
44. Turpeenniemi-Hujanen T. Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers. Biochimie 2005;87:287-97.
45. McCawley LJ, Matrisian LM. Matrix metalloproteinases: multifunctional contributors to tumor progression. Mol Med Today 2000;6:149-56.
46. Neely KA, Bressler NM, Bressler SB. Clinical characteristics, epidemiology, and natural history of age-related macular degeneration. Ophthalmol Clin North Am 1993;2:291-306.
47. Shen LX, Basilion JP, Stanton VP Jr. Single-nucleotide polymorphisms can cause different structural folds of mRNA. Proc Natl Acad Sci U S A 1999;96:7871-6.